Fosun Capital

Fosun Capital, part of China's largest private conglomerate Fosun, focuses on pharmaceutical and healthcare investments. The firm's investment strategy spans various stages, with a particular emphasis on Series A and Series C rounds. While specific investment sizes are not disclosed, their portfolio reflects a range from early-stage to growth-stage companies.

Notable portfolio companies include Arterys, a medical imaging AI platform, Iflytek, a leader in intelligent speech and AI technologies, and Sepax Technologies, specializing in chromatography products. Fosun Capital leverages its parent company's extensive resources in pharmaceuticals and healthcare to provide strategic value to its portfolio companies, potentially offering access to the vast Chinese market and industry expertise.